About: PF-514273

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

PF-514273 is a drug developed by Pfizer, which acts as an extremely selective antagonist for the CB1 receptor, with approximately 10,000x selectivity over the closely related CB2 receptor. This very high selectivity makes it useful for scientific research into these receptors, as many commonly used cannabinoid receptor antagonists also block the CB2 receptor to some extent.

Property	Value
dbo:abstract	PF-514273 is a drug developed by Pfizer, which acts as an extremely selective antagonist for the CB1 receptor, with approximately 10,000x selectivity over the closely related CB2 receptor. This very high selectivity makes it useful for scientific research into these receptors, as many commonly used cannabinoid receptor antagonists also block the CB2 receptor to some extent. (en)
dbo:casNumber	851728-60-4
dbo:fdaUniiCode	45FRJ4YGM2
dbo:pubchem	11316919
dbo:thumbnail	wiki-commons:Special:FilePath/PF-514273_Structure.svg?width=300
dbo:wikiPageID	34540359 (xsd:integer)
dbo:wikiPageLength	2277 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1082425926 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Pfizer dbc:Cannabinoids dbc:Pfizer_brands dbr:Receptor_antagonist dbr:Receptor_(biochemistry) dbc:CB1_receptor_antagonists dbr:Cannabinoid_receptor_antagonist dbr:Cannabinoid_receptor_1 dbr:Cannabinoid_receptor_2
dbp:c	21 (xsd:integer)
dbp:casNumber	851728 (xsd:integer)
dbp:chemspiderid	9491886 (xsd:integer)
dbp:cl	2 (xsd:integer)
dbp:f	2 (xsd:integer)
dbp:h	17 (xsd:integer)
dbp:iupacName	2 (xsd:integer)
dbp:n	3 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:pubchem	11316919 (xsd:integer)
dbp:smiles	O=C1NCCOc2c1nn-c3ccccc3Cl (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	FJMQJSUOOGOWBD-UHFFFAOYSA-N (en)
dbp:unii	45 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:width	220 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Cannabinoid-stub dbt:Cannabinoids dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Fdacite
dcterms:subject	dbc:Cannabinoids dbc:Pfizer_brands dbc:CB1_receptor_antagonists
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatCB1ReceptorAntagonists yago:Adversary109773245 yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Whole100003553
rdfs:comment	PF-514273 is a drug developed by Pfizer, which acts as an extremely selective antagonist for the CB1 receptor, with approximately 10,000x selectivity over the closely related CB2 receptor. This very high selectivity makes it useful for scientific research into these receptors, as many commonly used cannabinoid receptor antagonists also block the CB2 receptor to some extent. (en)
rdfs:label	PF-514273 (en)
owl:sameAs	freebase:PF-514273 yago-res:PF-514273 wikidata:PF-514273 dbpedia-sh:PF-514273 dbpedia-sr:PF-514273 https://global.dbpedia.org/id/4skFm
prov:wasDerivedFrom	wikipedia-en:PF-514273?oldid=1082425926&ns=0
foaf:depiction	wiki-commons:Special:FilePath/PF-514273_Structure.svg
foaf:isPrimaryTopicOf	wikipedia-en:PF-514273
is dbo:wikiPageWikiLink of	dbr:List_of_psychedelic_drugs
is foaf:primaryTopic of	wikipedia-en:PF-514273